GlassScriptPhysician profile
Kir-Wei Chen
NPI 1356787832
$2,057.21
in general payments reported to CMS, 2019-2025
19 companies · $892 in 2025
The $892 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $51.27 · 2021: $607 · 2022: $111 · 2023: $218 · 2024: $74.04 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.95 |
| Travel and Lodging | $256.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $716.16 | 2025 | |
| Abbvie INC. | $210.26 | 2019-2022 | |
| Hologic Sales and Service, LLC | $201.40 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Mission Pharmacal Company | $154.39 | 2020-2024 | Ferralet 90, Citranatal, Uribel Tabs |
| Biogen, INC. | $153.30 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $139.52 | 2021 | |
| Myovant Sciences INC. | $118.14 | 2021 | |
| Mayne Pharma Commercial LLC | $56.75 | 2023-2024 | |
| Caldera Medical, INC | $49.49 | 2022 | |
| Pfizer INC. | $37.45 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $32.33 | 2023 | Myfembree |
| Roche Diagnostics Corporation | $32.17 | 2019 | |
| Ethicon US, LLC | $32.09 | 2024 | Vistaseal |
| Agile Therapeutics, INC. | $29.64 | 2021 | |
| Applied Medical Resources Corporation | $20.30 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19.46 | 2021 | |
| Avion Pharmaceuticals | $19.39 | 2023 | Balcoltra |
| Lupin INC. | $17.83 | 2019 | |
| Exeltis, USA INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kir-Wei Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.